Copyright Reports & Markets. All rights reserved.

Global Osimertinib Generics Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Osimertinib Generics Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 40mg per Tablet
    • 1.3.3 80mg per Tablet
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Osimertinib Generics Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital and Clinic
    • 1.4.3 Retail Pharmacies
    • 1.4.4 Other
  • 1.5 Global Osimertinib Generics Market Size & Forecast
    • 1.5.1 Global Osimertinib Generics Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Osimertinib Generics Sales Quantity (2021-2032)
    • 1.5.3 Global Osimertinib Generics Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Zydus
    • 2.1.1 Zydus Details
    • 2.1.2 Zydus Major Business
    • 2.1.3 Zydus Osimertinib Generics Product and Services
    • 2.1.4 Zydus Osimertinib Generics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Zydus Recent Developments/Updates
  • 2.2 Wanbang Biopharmaceuticals
    • 2.2.1 Wanbang Biopharmaceuticals Details
    • 2.2.2 Wanbang Biopharmaceuticals Major Business
    • 2.2.3 Wanbang Biopharmaceuticals Osimertinib Generics Product and Services
    • 2.2.4 Wanbang Biopharmaceuticals Osimertinib Generics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Wanbang Biopharmaceuticals Recent Developments/Updates
  • 2.3 Drug International
    • 2.3.1 Drug International Details
    • 2.3.2 Drug International Major Business
    • 2.3.3 Drug International Osimertinib Generics Product and Services
    • 2.3.4 Drug International Osimertinib Generics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Drug International Recent Developments/Updates
  • 2.4 Beacon
    • 2.4.1 Beacon Details
    • 2.4.2 Beacon Major Business
    • 2.4.3 Beacon Osimertinib Generics Product and Services
    • 2.4.4 Beacon Osimertinib Generics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Beacon Recent Developments/Updates
  • 2.5 General Pharmaceuticals
    • 2.5.1 General Pharmaceuticals Details
    • 2.5.2 General Pharmaceuticals Major Business
    • 2.5.3 General Pharmaceuticals Osimertinib Generics Product and Services
    • 2.5.4 General Pharmaceuticals Osimertinib Generics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 General Pharmaceuticals Recent Developments/Updates
  • 2.6 Pharmacil
    • 2.6.1 Pharmacil Details
    • 2.6.2 Pharmacil Major Business
    • 2.6.3 Pharmacil Osimertinib Generics Product and Services
    • 2.6.4 Pharmacil Osimertinib Generics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Pharmacil Recent Developments/Updates

3 Competitive Environment: Osimertinib Generics by Manufacturer

  • 3.1 Global Osimertinib Generics Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Osimertinib Generics Revenue by Manufacturer (2021-2026)
  • 3.3 Global Osimertinib Generics Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Osimertinib Generics by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Osimertinib Generics Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Osimertinib Generics Manufacturer Market Share in 2025
  • 3.5 Osimertinib Generics Market: Overall Company Footprint Analysis
    • 3.5.1 Osimertinib Generics Market: Region Footprint
    • 3.5.2 Osimertinib Generics Market: Company Product Type Footprint
    • 3.5.3 Osimertinib Generics Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Osimertinib Generics Market Size by Region
    • 4.1.1 Global Osimertinib Generics Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Osimertinib Generics Consumption Value by Region (2021-2032)
    • 4.1.3 Global Osimertinib Generics Average Price by Region (2021-2032)
  • 4.2 North America Osimertinib Generics Consumption Value (2021-2032)
  • 4.3 Europe Osimertinib Generics Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Osimertinib Generics Consumption Value (2021-2032)
  • 4.5 South America Osimertinib Generics Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Osimertinib Generics Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Osimertinib Generics Sales Quantity by Type (2021-2032)
  • 5.2 Global Osimertinib Generics Consumption Value by Type (2021-2032)
  • 5.3 Global Osimertinib Generics Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Osimertinib Generics Sales Quantity by Application (2021-2032)
  • 6.2 Global Osimertinib Generics Consumption Value by Application (2021-2032)
  • 6.3 Global Osimertinib Generics Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Osimertinib Generics Sales Quantity by Type (2021-2032)
  • 7.2 North America Osimertinib Generics Sales Quantity by Application (2021-2032)
  • 7.3 North America Osimertinib Generics Market Size by Country
    • 7.3.1 North America Osimertinib Generics Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Osimertinib Generics Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Osimertinib Generics Sales Quantity by Type (2021-2032)
  • 8.2 Europe Osimertinib Generics Sales Quantity by Application (2021-2032)
  • 8.3 Europe Osimertinib Generics Market Size by Country
    • 8.3.1 Europe Osimertinib Generics Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Osimertinib Generics Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Osimertinib Generics Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Osimertinib Generics Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Osimertinib Generics Market Size by Region
    • 9.3.1 Asia-Pacific Osimertinib Generics Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Osimertinib Generics Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Osimertinib Generics Sales Quantity by Type (2021-2032)
  • 10.2 South America Osimertinib Generics Sales Quantity by Application (2021-2032)
  • 10.3 South America Osimertinib Generics Market Size by Country
    • 10.3.1 South America Osimertinib Generics Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Osimertinib Generics Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Osimertinib Generics Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Osimertinib Generics Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Osimertinib Generics Market Size by Country
    • 11.3.1 Middle East & Africa Osimertinib Generics Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Osimertinib Generics Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Osimertinib Generics Market Drivers
  • 12.2 Osimertinib Generics Market Restraints
  • 12.3 Osimertinib Generics Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Osimertinib Generics and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Osimertinib Generics
  • 13.3 Osimertinib Generics Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Osimertinib Generics Typical Distributors
  • 14.3 Osimertinib Generics Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Osimertinib Generics market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    Osimertinib generics refer to alternative versions of the drug osimertinib,which is used to treat non-small cell lung cancer (NSCLC) with EGFR mutations,including the T790M mutation.Generic osimertinib tablets contain the same active ingredient and are designed to have the same therapeutic effect as the branded version, inhibiting the EGFR tyrosine kinase to slow down or stop cancer cell growth.
    This report is a detailed and comprehensive analysis for global Osimertinib Generics market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Osimertinib Generics market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Osimertinib Generics market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Osimertinib Generics market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Osimertinib Generics market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Osimertinib Generics
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Osimertinib Generics market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Zydus, Wanbang Biopharmaceuticals, Drug International, Beacon, General Pharmaceuticals, Pharmacil, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Osimertinib Generics market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    40mg per Tablet
    80mg per Tablet
    Market segment by Application
    Hospital and Clinic
    Retail Pharmacies
    Other
    Major players covered
    Zydus
    Wanbang Biopharmaceuticals
    Drug International
    Beacon
    General Pharmaceuticals
    Pharmacil
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Osimertinib Generics product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Osimertinib Generics, with price, sales quantity, revenue, and global market share of Osimertinib Generics from 2021 to 2026.
    Chapter 3, the Osimertinib Generics competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Osimertinib Generics breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Osimertinib Generics market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Osimertinib Generics.
    Chapter 14 and 15, to describe Osimertinib Generics sales channel, distributors, customers, research findings and conclusion.

    Buy now